Search

Your search keyword '"Comoglio, Paolo"' showing total 1,232 results
Start Over Author "Comoglio, Paolo"
1,232 results on '"Comoglio, Paolo"'

3. Coexisting cancer stem cells with heterogeneous gene amplifications, transcriptional profiles, and malignancy are isolated from single glioblastomas

Author

De Bacco, Francesca, Orzan, Francesca, Crisafulli, Giovanni, Prelli, Marta, Isella, Claudio, Casanova, Elena, Albano, Raffaella, Reato, Gigliola, Erriquez, Jessica, D’Ambrosio, Antonio, Panero, Mara, Dall’Aglio, Carmine, Casorzo, Laura, Cominelli, Manuela, Pagani, Francesca, Melcarne, Antonio, Zeppa, Pietro, Altieri, Roberto, Morra, Isabella, Cassoni, Paola, Garbossa, Diego, Cassisa, Anna, Bartolini, Alice, Pellegatta, Serena, Comoglio, Paolo M., Finocchiaro, Gaetano, Poliani, Pietro L., and Boccaccio, Carla

Published
2023
Full Text
View/download PDF

14. Increased Lactate Secretion by Cancer Cells Sustains Non-cell-autonomous Adaptive Resistance to MET and EGFR Targeted Therapies

Author

Apicella, Maria, Giannoni, Elisa, Fiore, Stephany, Ferrari, Karin Johanna, Fernández-Pérez, Daniel, Isella, Claudio, Granchi, Carlotta, Minutolo, Filippo, Sottile, Antonino, Comoglio, Paolo Maria, Medico, Enzo, Pietrantonio, Filippo, Volante, Marco, Pasini, Diego, Chiarugi, Paola, Giordano, Silvia, and Corso, Simona

Published
2018
Full Text
View/download PDF

19. MET Oncogene Enhances Pro-Migratory Functions by Counteracting NMDAR2B Cleavage.

Author

Gallo, Simona, Vitacolonna, Annapia, Comoglio, Paolo Maria, and Crepaldi, Tiziana

Subjects
HEPATOCYTE growth factor, CANCER cell growth, LIGAND-gated ion channels, METHYL aspartate receptors, ONCOGENES, CELL migration, ION channels
Abstract

The involvement of the N-methyl-D-aspartate receptor (NMDAR), a glutamate-gated ion channel, in promoting the invasive growth of cancer cells is an area of ongoing investigation. Our previous findings revealed a physical interaction between NMDAR and MET, the hepatocyte growth factor (HGF) receptor. However, the molecular mechanisms underlying this NMDAR/MET interaction remain unclear. In this study, we demonstrate that the NMDAR2B subunit undergoes proteolytic processing, resulting in a low-molecular-weight form of 100 kDa. Interestingly, when the NMDAR2B and MET constructs were co-transfected, the full-size high-molecular-weight NMDAR2B form of 160 kDa was predominantly observed. The protection of NMDAR2B from cleavage was dependent on the kinase activity of MET. We provide the following evidence that MET opposes the autophagic lysosomal proteolysis of NMDAR2B: (i) MET decreased the protein levels of lysosomal cathepsins; (ii) treatment with either an inhibitor of autophagosome formation or the fusion of the autophagosome and lysosome elevated the proportion of the NMDAR2B protein's uncleaved form; (iii) a specific mTOR inhibitor hindered the anti-autophagic effect of MET. Finally, we demonstrate that MET coopts NMDAR2B to augment cell migration. This implies that MET harnesses the functionality of NMDAR2B to enhance the ability of cancer cells to migrate. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

24. Supplementary Figure S2 from Amplification of the MET Receptor Drives Resistance to Anti-EGFR Therapies in Colorectal Cancer

Author

Bardelli, Alberto, primary, Corso, Simona, primary, Bertotti, Andrea, primary, Hobor, Sebastijan, primary, Valtorta, Emanuele, primary, Siravegna, Giulia, primary, Sartore-Bianchi, Andrea, primary, Scala, Elisa, primary, Cassingena, Andrea, primary, Zecchin, Davide, primary, Apicella, Maria, primary, Migliardi, Giorgia, primary, Galimi, Francesco, primary, Lauricella, Calogero, primary, Zanon, Carlo, primary, Perera, Timothy, primary, Veronese, Silvio, primary, Corti, Giorgio, primary, Amatu, Alessio, primary, Gambacorta, Marcello, primary, Diaz, Luis A., primary, Sausen, Mark, primary, Velculescu, Victor E., primary, Comoglio, Paolo, primary, Trusolino, Livio, primary, Di Nicolantonio, Federica, primary, Giordano, Silvia, primary, and Siena, Salvatore, primary

Published
2023
Full Text
View/download PDF

25. Supplementary Data 2 from Liquid Biopsy of Cerebrospinal Fluid Enables Selective Profiling of Glioma Molecular Subtypes at First Clinical Presentation

Author

Orzan, Francesca, primary, De Bacco, Francesca, primary, Lazzarini, Elisabetta, primary, Crisafulli, Giovanni, primary, Gasparini, Alessandra, primary, Dipasquale, Angelo, primary, Barault, Ludovic, primary, Macagno, Marco, primary, Persico, Pasquale, primary, Pessina, Federico, primary, Bono, Beatrice, primary, Giordano, Laura, primary, Zeppa, Pietro, primary, Melcarne, Antonio, primary, Cassoni, Paola, primary, Garbossa, Diego, primary, Santoro, Armando, primary, Comoglio, Paolo M., primary, Indraccolo, Stefano, primary, Simonelli, Matteo, primary, and Boccaccio, Carla, primary

Published
2023
Full Text
View/download PDF

26. Supplementary Table 1 from A Molecularly Annotated Platform of Patient-Derived Xenografts (“Xenopatients”) Identifies HER2 as an Effective Therapeutic Target in Cetuximab-Resistant Colorectal Cancer

Author

Bertotti, Andrea, primary, Migliardi, Giorgia, primary, Galimi, Francesco, primary, Sassi, Francesco, primary, Torti, Davide, primary, Isella, Claudio, primary, Corà, Davide, primary, Di Nicolantonio, Federica, primary, Buscarino, Michela, primary, Petti, Consalvo, primary, Ribero, Dario, primary, Russolillo, Nadia, primary, Muratore, Andrea, primary, Massucco, Paolo, primary, Pisacane, Alberto, primary, Molinaro, Luca, primary, Valtorta, Emanuele, primary, Sartore-Bianchi, Andrea, primary, Risio, Mauro, primary, Capussotti, Lorenzo, primary, Gambacorta, Marcello, primary, Siena, Salvatore, primary, Medico, Enzo, primary, Sapino, Anna, primary, Marsoni, Silvia, primary, Comoglio, Paolo M., primary, Bardelli, Alberto, primary, and Trusolino, Livio, primary

Published
2023
Full Text
View/download PDF

27. Supplementary Figure 2 from A Molecularly Annotated Platform of Patient-Derived Xenografts (“Xenopatients”) Identifies HER2 as an Effective Therapeutic Target in Cetuximab-Resistant Colorectal Cancer

Author

Bertotti, Andrea, primary, Migliardi, Giorgia, primary, Galimi, Francesco, primary, Sassi, Francesco, primary, Torti, Davide, primary, Isella, Claudio, primary, Corà, Davide, primary, Di Nicolantonio, Federica, primary, Buscarino, Michela, primary, Petti, Consalvo, primary, Ribero, Dario, primary, Russolillo, Nadia, primary, Muratore, Andrea, primary, Massucco, Paolo, primary, Pisacane, Alberto, primary, Molinaro, Luca, primary, Valtorta, Emanuele, primary, Sartore-Bianchi, Andrea, primary, Risio, Mauro, primary, Capussotti, Lorenzo, primary, Gambacorta, Marcello, primary, Siena, Salvatore, primary, Medico, Enzo, primary, Sapino, Anna, primary, Marsoni, Silvia, primary, Comoglio, Paolo M., primary, Bardelli, Alberto, primary, and Trusolino, Livio, primary

Published
2023
Full Text
View/download PDF

28. Supplementary Figure S1 from S49076 Is a Novel Kinase Inhibitor of MET, AXL, and FGFR with Strong Preclinical Activity Alone and in Association with Bevacizumab

Author

Burbridge, Mike F., primary, Bossard, Céline J., primary, Saunier, Carine, primary, Fejes, Imre, primary, Bruno, Alain, primary, Léonce, Stéphane, primary, Ferry, Gilles, primary, Da Violante, Georges, primary, Bouzom, François, primary, Cattan, Valérie, primary, Jacquet-Bescond, Anne, primary, Comoglio, Paolo M., primary, Lockhart, Brian P., primary, Boutin, Jean A., primary, Cordi, Alex, primary, Ortuno, Jean-Claude, primary, Pierré, Alain, primary, Hickman, John A., primary, Cruzalegui, Francisco H., primary, and Depil, Stéphane, primary

Published
2023
Full Text
View/download PDF

29. Supplementary Table 3 from A Molecularly Annotated Platform of Patient-Derived Xenografts (“Xenopatients”) Identifies HER2 as an Effective Therapeutic Target in Cetuximab-Resistant Colorectal Cancer

Author

Bertotti, Andrea, primary, Migliardi, Giorgia, primary, Galimi, Francesco, primary, Sassi, Francesco, primary, Torti, Davide, primary, Isella, Claudio, primary, Corà, Davide, primary, Di Nicolantonio, Federica, primary, Buscarino, Michela, primary, Petti, Consalvo, primary, Ribero, Dario, primary, Russolillo, Nadia, primary, Muratore, Andrea, primary, Massucco, Paolo, primary, Pisacane, Alberto, primary, Molinaro, Luca, primary, Valtorta, Emanuele, primary, Sartore-Bianchi, Andrea, primary, Risio, Mauro, primary, Capussotti, Lorenzo, primary, Gambacorta, Marcello, primary, Siena, Salvatore, primary, Medico, Enzo, primary, Sapino, Anna, primary, Marsoni, Silvia, primary, Comoglio, Paolo M., primary, Bardelli, Alberto, primary, and Trusolino, Livio, primary

Published
2023
Full Text
View/download PDF

30. Supplementary Figure Legends from S49076 Is a Novel Kinase Inhibitor of MET, AXL, and FGFR with Strong Preclinical Activity Alone and in Association with Bevacizumab

Author

Burbridge, Mike F., primary, Bossard, Céline J., primary, Saunier, Carine, primary, Fejes, Imre, primary, Bruno, Alain, primary, Léonce, Stéphane, primary, Ferry, Gilles, primary, Da Violante, Georges, primary, Bouzom, François, primary, Cattan, Valérie, primary, Jacquet-Bescond, Anne, primary, Comoglio, Paolo M., primary, Lockhart, Brian P., primary, Boutin, Jean A., primary, Cordi, Alex, primary, Ortuno, Jean-Claude, primary, Pierré, Alain, primary, Hickman, John A., primary, Cruzalegui, Francisco H., primary, and Depil, Stéphane, primary

Published
2023
Full Text
View/download PDF

31. Supplementary Figure 1 from A Molecularly Annotated Platform of Patient-Derived Xenografts (“Xenopatients”) Identifies HER2 as an Effective Therapeutic Target in Cetuximab-Resistant Colorectal Cancer

Author

Bertotti, Andrea, primary, Migliardi, Giorgia, primary, Galimi, Francesco, primary, Sassi, Francesco, primary, Torti, Davide, primary, Isella, Claudio, primary, Corà, Davide, primary, Di Nicolantonio, Federica, primary, Buscarino, Michela, primary, Petti, Consalvo, primary, Ribero, Dario, primary, Russolillo, Nadia, primary, Muratore, Andrea, primary, Massucco, Paolo, primary, Pisacane, Alberto, primary, Molinaro, Luca, primary, Valtorta, Emanuele, primary, Sartore-Bianchi, Andrea, primary, Risio, Mauro, primary, Capussotti, Lorenzo, primary, Gambacorta, Marcello, primary, Siena, Salvatore, primary, Medico, Enzo, primary, Sapino, Anna, primary, Marsoni, Silvia, primary, Comoglio, Paolo M., primary, Bardelli, Alberto, primary, and Trusolino, Livio, primary

Published
2023
Full Text
View/download PDF

32. Supplementary Table S1 from S49076 Is a Novel Kinase Inhibitor of MET, AXL, and FGFR with Strong Preclinical Activity Alone and in Association with Bevacizumab

Author

Burbridge, Mike F., primary, Bossard, Céline J., primary, Saunier, Carine, primary, Fejes, Imre, primary, Bruno, Alain, primary, Léonce, Stéphane, primary, Ferry, Gilles, primary, Da Violante, Georges, primary, Bouzom, François, primary, Cattan, Valérie, primary, Jacquet-Bescond, Anne, primary, Comoglio, Paolo M., primary, Lockhart, Brian P., primary, Boutin, Jean A., primary, Cordi, Alex, primary, Ortuno, Jean-Claude, primary, Pierré, Alain, primary, Hickman, John A., primary, Cruzalegui, Francisco H., primary, and Depil, Stéphane, primary

Published
2023
Full Text
View/download PDF

33. Supplementary Figure 3 from A Molecularly Annotated Platform of Patient-Derived Xenografts (“Xenopatients”) Identifies HER2 as an Effective Therapeutic Target in Cetuximab-Resistant Colorectal Cancer

Author

Bertotti, Andrea, primary, Migliardi, Giorgia, primary, Galimi, Francesco, primary, Sassi, Francesco, primary, Torti, Davide, primary, Isella, Claudio, primary, Corà, Davide, primary, Di Nicolantonio, Federica, primary, Buscarino, Michela, primary, Petti, Consalvo, primary, Ribero, Dario, primary, Russolillo, Nadia, primary, Muratore, Andrea, primary, Massucco, Paolo, primary, Pisacane, Alberto, primary, Molinaro, Luca, primary, Valtorta, Emanuele, primary, Sartore-Bianchi, Andrea, primary, Risio, Mauro, primary, Capussotti, Lorenzo, primary, Gambacorta, Marcello, primary, Siena, Salvatore, primary, Medico, Enzo, primary, Sapino, Anna, primary, Marsoni, Silvia, primary, Comoglio, Paolo M., primary, Bardelli, Alberto, primary, and Trusolino, Livio, primary

Published
2023
Full Text
View/download PDF

34. Supplementary Figure 5 from A Molecularly Annotated Platform of Patient-Derived Xenografts (“Xenopatients”) Identifies HER2 as an Effective Therapeutic Target in Cetuximab-Resistant Colorectal Cancer

Author

Bertotti, Andrea, primary, Migliardi, Giorgia, primary, Galimi, Francesco, primary, Sassi, Francesco, primary, Torti, Davide, primary, Isella, Claudio, primary, Corà, Davide, primary, Di Nicolantonio, Federica, primary, Buscarino, Michela, primary, Petti, Consalvo, primary, Ribero, Dario, primary, Russolillo, Nadia, primary, Muratore, Andrea, primary, Massucco, Paolo, primary, Pisacane, Alberto, primary, Molinaro, Luca, primary, Valtorta, Emanuele, primary, Sartore-Bianchi, Andrea, primary, Risio, Mauro, primary, Capussotti, Lorenzo, primary, Gambacorta, Marcello, primary, Siena, Salvatore, primary, Medico, Enzo, primary, Sapino, Anna, primary, Marsoni, Silvia, primary, Comoglio, Paolo M., primary, Bardelli, Alberto, primary, and Trusolino, Livio, primary

Published
2023
Full Text
View/download PDF

35. Data from A Molecularly Annotated Platform of Patient-Derived Xenografts (“Xenopatients”) Identifies HER2 as an Effective Therapeutic Target in Cetuximab-Resistant Colorectal Cancer

Author

Bertotti, Andrea, primary, Migliardi, Giorgia, primary, Galimi, Francesco, primary, Sassi, Francesco, primary, Torti, Davide, primary, Isella, Claudio, primary, Corà, Davide, primary, Di Nicolantonio, Federica, primary, Buscarino, Michela, primary, Petti, Consalvo, primary, Ribero, Dario, primary, Russolillo, Nadia, primary, Muratore, Andrea, primary, Massucco, Paolo, primary, Pisacane, Alberto, primary, Molinaro, Luca, primary, Valtorta, Emanuele, primary, Sartore-Bianchi, Andrea, primary, Risio, Mauro, primary, Capussotti, Lorenzo, primary, Gambacorta, Marcello, primary, Siena, Salvatore, primary, Medico, Enzo, primary, Sapino, Anna, primary, Marsoni, Silvia, primary, Comoglio, Paolo M., primary, Bardelli, Alberto, primary, and Trusolino, Livio, primary

Published
2023
Full Text
View/download PDF

36. Supplementary Figure 4 from A Molecularly Annotated Platform of Patient-Derived Xenografts (“Xenopatients”) Identifies HER2 as an Effective Therapeutic Target in Cetuximab-Resistant Colorectal Cancer

Author

Bertotti, Andrea, primary, Migliardi, Giorgia, primary, Galimi, Francesco, primary, Sassi, Francesco, primary, Torti, Davide, primary, Isella, Claudio, primary, Corà, Davide, primary, Di Nicolantonio, Federica, primary, Buscarino, Michela, primary, Petti, Consalvo, primary, Ribero, Dario, primary, Russolillo, Nadia, primary, Muratore, Andrea, primary, Massucco, Paolo, primary, Pisacane, Alberto, primary, Molinaro, Luca, primary, Valtorta, Emanuele, primary, Sartore-Bianchi, Andrea, primary, Risio, Mauro, primary, Capussotti, Lorenzo, primary, Gambacorta, Marcello, primary, Siena, Salvatore, primary, Medico, Enzo, primary, Sapino, Anna, primary, Marsoni, Silvia, primary, Comoglio, Paolo M., primary, Bardelli, Alberto, primary, and Trusolino, Livio, primary

Published
2023
Full Text
View/download PDF

37. Supplementary Figure Legend from Amplification of the MET Receptor Drives Resistance to Anti-EGFR Therapies in Colorectal Cancer

Author

Bardelli, Alberto, primary, Corso, Simona, primary, Bertotti, Andrea, primary, Hobor, Sebastijan, primary, Valtorta, Emanuele, primary, Siravegna, Giulia, primary, Sartore-Bianchi, Andrea, primary, Scala, Elisa, primary, Cassingena, Andrea, primary, Zecchin, Davide, primary, Apicella, Maria, primary, Migliardi, Giorgia, primary, Galimi, Francesco, primary, Lauricella, Calogero, primary, Zanon, Carlo, primary, Perera, Timothy, primary, Veronese, Silvio, primary, Corti, Giorgio, primary, Amatu, Alessio, primary, Gambacorta, Marcello, primary, Diaz, Luis A., primary, Sausen, Mark, primary, Velculescu, Victor E., primary, Comoglio, Paolo, primary, Trusolino, Livio, primary, Di Nicolantonio, Federica, primary, Giordano, Silvia, primary, and Siena, Salvatore, primary

Published
2023
Full Text
View/download PDF

38. Data from Liquid Biopsy of Cerebrospinal Fluid Enables Selective Profiling of Glioma Molecular Subtypes at First Clinical Presentation

Author

Orzan, Francesca, primary, De Bacco, Francesca, primary, Lazzarini, Elisabetta, primary, Crisafulli, Giovanni, primary, Gasparini, Alessandra, primary, Dipasquale, Angelo, primary, Barault, Ludovic, primary, Macagno, Marco, primary, Persico, Pasquale, primary, Pessina, Federico, primary, Bono, Beatrice, primary, Giordano, Laura, primary, Zeppa, Pietro, primary, Melcarne, Antonio, primary, Cassoni, Paola, primary, Garbossa, Diego, primary, Santoro, Armando, primary, Comoglio, Paolo M., primary, Indraccolo, Stefano, primary, Simonelli, Matteo, primary, and Boccaccio, Carla, primary

Published
2023
Full Text
View/download PDF

39. Data from Amplification of the MET Receptor Drives Resistance to Anti-EGFR Therapies in Colorectal Cancer

Author

Bardelli, Alberto, primary, Corso, Simona, primary, Bertotti, Andrea, primary, Hobor, Sebastijan, primary, Valtorta, Emanuele, primary, Siravegna, Giulia, primary, Sartore-Bianchi, Andrea, primary, Scala, Elisa, primary, Cassingena, Andrea, primary, Zecchin, Davide, primary, Apicella, Maria, primary, Migliardi, Giorgia, primary, Galimi, Francesco, primary, Lauricella, Calogero, primary, Zanon, Carlo, primary, Perera, Timothy, primary, Veronese, Silvio, primary, Corti, Giorgio, primary, Amatu, Alessio, primary, Gambacorta, Marcello, primary, Diaz, Luis A., primary, Sausen, Mark, primary, Velculescu, Victor E., primary, Comoglio, Paolo, primary, Trusolino, Livio, primary, Di Nicolantonio, Federica, primary, Giordano, Silvia, primary, and Siena, Salvatore, primary

Published
2023
Full Text
View/download PDF

40. Supplementary Figure 6 from A Molecularly Annotated Platform of Patient-Derived Xenografts (“Xenopatients”) Identifies HER2 as an Effective Therapeutic Target in Cetuximab-Resistant Colorectal Cancer

Author

Bertotti, Andrea, primary, Migliardi, Giorgia, primary, Galimi, Francesco, primary, Sassi, Francesco, primary, Torti, Davide, primary, Isella, Claudio, primary, Corà, Davide, primary, Di Nicolantonio, Federica, primary, Buscarino, Michela, primary, Petti, Consalvo, primary, Ribero, Dario, primary, Russolillo, Nadia, primary, Muratore, Andrea, primary, Massucco, Paolo, primary, Pisacane, Alberto, primary, Molinaro, Luca, primary, Valtorta, Emanuele, primary, Sartore-Bianchi, Andrea, primary, Risio, Mauro, primary, Capussotti, Lorenzo, primary, Gambacorta, Marcello, primary, Siena, Salvatore, primary, Medico, Enzo, primary, Sapino, Anna, primary, Marsoni, Silvia, primary, Comoglio, Paolo M., primary, Bardelli, Alberto, primary, and Trusolino, Livio, primary

Published
2023
Full Text
View/download PDF

41. Supplementary Table 2 from A Molecularly Annotated Platform of Patient-Derived Xenografts (“Xenopatients”) Identifies HER2 as an Effective Therapeutic Target in Cetuximab-Resistant Colorectal Cancer

Author

Bertotti, Andrea, primary, Migliardi, Giorgia, primary, Galimi, Francesco, primary, Sassi, Francesco, primary, Torti, Davide, primary, Isella, Claudio, primary, Corà, Davide, primary, Di Nicolantonio, Federica, primary, Buscarino, Michela, primary, Petti, Consalvo, primary, Ribero, Dario, primary, Russolillo, Nadia, primary, Muratore, Andrea, primary, Massucco, Paolo, primary, Pisacane, Alberto, primary, Molinaro, Luca, primary, Valtorta, Emanuele, primary, Sartore-Bianchi, Andrea, primary, Risio, Mauro, primary, Capussotti, Lorenzo, primary, Gambacorta, Marcello, primary, Siena, Salvatore, primary, Medico, Enzo, primary, Sapino, Anna, primary, Marsoni, Silvia, primary, Comoglio, Paolo M., primary, Bardelli, Alberto, primary, and Trusolino, Livio, primary

Published
2023
Full Text
View/download PDF

42. Supplementary Information 1 from Liquid Biopsy of Cerebrospinal Fluid Enables Selective Profiling of Glioma Molecular Subtypes at First Clinical Presentation

Author

Orzan, Francesca, primary, De Bacco, Francesca, primary, Lazzarini, Elisabetta, primary, Crisafulli, Giovanni, primary, Gasparini, Alessandra, primary, Dipasquale, Angelo, primary, Barault, Ludovic, primary, Macagno, Marco, primary, Persico, Pasquale, primary, Pessina, Federico, primary, Bono, Beatrice, primary, Giordano, Laura, primary, Zeppa, Pietro, primary, Melcarne, Antonio, primary, Cassoni, Paola, primary, Garbossa, Diego, primary, Santoro, Armando, primary, Comoglio, Paolo M., primary, Indraccolo, Stefano, primary, Simonelli, Matteo, primary, and Boccaccio, Carla, primary

Published
2023
Full Text
View/download PDF

43. Supplementary Data 3 from Liquid Biopsy of Cerebrospinal Fluid Enables Selective Profiling of Glioma Molecular Subtypes at First Clinical Presentation

Author

Orzan, Francesca, primary, De Bacco, Francesca, primary, Lazzarini, Elisabetta, primary, Crisafulli, Giovanni, primary, Gasparini, Alessandra, primary, Dipasquale, Angelo, primary, Barault, Ludovic, primary, Macagno, Marco, primary, Persico, Pasquale, primary, Pessina, Federico, primary, Bono, Beatrice, primary, Giordano, Laura, primary, Zeppa, Pietro, primary, Melcarne, Antonio, primary, Cassoni, Paola, primary, Garbossa, Diego, primary, Santoro, Armando, primary, Comoglio, Paolo M., primary, Indraccolo, Stefano, primary, Simonelli, Matteo, primary, and Boccaccio, Carla, primary

Published
2023
Full Text
View/download PDF

44. Supplementary Data 1 from Liquid Biopsy of Cerebrospinal Fluid Enables Selective Profiling of Glioma Molecular Subtypes at First Clinical Presentation

Author

Orzan, Francesca, primary, De Bacco, Francesca, primary, Lazzarini, Elisabetta, primary, Crisafulli, Giovanni, primary, Gasparini, Alessandra, primary, Dipasquale, Angelo, primary, Barault, Ludovic, primary, Macagno, Marco, primary, Persico, Pasquale, primary, Pessina, Federico, primary, Bono, Beatrice, primary, Giordano, Laura, primary, Zeppa, Pietro, primary, Melcarne, Antonio, primary, Cassoni, Paola, primary, Garbossa, Diego, primary, Santoro, Armando, primary, Comoglio, Paolo M., primary, Indraccolo, Stefano, primary, Simonelli, Matteo, primary, and Boccaccio, Carla, primary

Published
2023
Full Text
View/download PDF

45. Supplementary Figure 3 from MiR-1 Downregulation Cooperates with MACC1 in Promoting MET Overexpression in Human Colon Cancer

Author

Migliore, Cristina, primary, Martin, Valentina, primary, Leoni, Vera P., primary, Restivo, Angelo, primary, Atzori, Luigi, primary, Petrelli, Annalisa, primary, Isella, Claudio, primary, Zorcolo, Luigi, primary, Sarotto, Ivana, primary, Casula, Giuseppe, primary, Comoglio, Paolo M., primary, Columbano, Amedeo, primary, and Giordano, Silvia, primary

Published
2023
Full Text
View/download PDF

46. Supplementary Table S4 from Genetic and Expression Analysis of MET, MACC1, and HGF in Metastatic Colorectal Cancer: Response to Met Inhibition in Patient Xenografts and Pathologic Correlations

Author

Galimi, Francesco, primary, Torti, Davide, primary, Sassi, Francesco, primary, Isella, Claudio, primary, Corà, Davide, primary, Gastaldi, Stefania, primary, Ribero, Dario, primary, Muratore, Andrea, primary, Massucco, Paolo, primary, Siatis, Dimitrios, primary, Paraluppi, Gianluca, primary, Gonella, Federica, primary, Maione, Francesca, primary, Pisacane, Alberto, primary, David, Ezio, primary, Torchio, Bruno, primary, Risio, Mauro, primary, Salizzoni, Mauro, primary, Capussotti, Lorenzo, primary, Perera, Timothy, primary, Medico, Enzo, primary, Di Renzo, Maria Flavia, primary, Comoglio, Paolo M., primary, Trusolino, Livio, primary, and Bertotti, Andrea, primary

Published
2023
Full Text
View/download PDF

47. Supplementary Figures S1-S6 from A Molecularly Annotated Model of Patient-Derived Colon Cancer Stem–Like Cells to Assess Genetic and Nongenetic Mechanisms of Resistance to Anti-EGFR Therapy

Author

Luraghi, Paolo, primary, Bigatto, Viola, primary, Cipriano, Elia, primary, Reato, Gigliola, primary, Orzan, Francesca, primary, Sassi, Francesco, primary, De Bacco, Francesca, primary, Isella, Claudio, primary, Bellomo, Sara E., primary, Medico, Enzo, primary, Comoglio, Paolo M., primary, Bertotti, Andrea, primary, Trusolino, Livio, primary, and Boccaccio, Carla, primary

Published
2023
Full Text
View/download PDF

48. Supplementary Experimental Procedures from A Molecularly Annotated Model of Patient-Derived Colon Cancer Stem–Like Cells to Assess Genetic and Nongenetic Mechanisms of Resistance to Anti-EGFR Therapy

Author

Luraghi, Paolo, primary, Bigatto, Viola, primary, Cipriano, Elia, primary, Reato, Gigliola, primary, Orzan, Francesca, primary, Sassi, Francesco, primary, De Bacco, Francesca, primary, Isella, Claudio, primary, Bellomo, Sara E., primary, Medico, Enzo, primary, Comoglio, Paolo M., primary, Bertotti, Andrea, primary, Trusolino, Livio, primary, and Boccaccio, Carla, primary

Published
2023
Full Text
View/download PDF

49. Supplementary Figure Legends 1-7 from MiR-1 Downregulation Cooperates with MACC1 in Promoting MET Overexpression in Human Colon Cancer

Author

Migliore, Cristina, primary, Martin, Valentina, primary, Leoni, Vera P., primary, Restivo, Angelo, primary, Atzori, Luigi, primary, Petrelli, Annalisa, primary, Isella, Claudio, primary, Zorcolo, Luigi, primary, Sarotto, Ivana, primary, Casula, Giuseppe, primary, Comoglio, Paolo M., primary, Columbano, Amedeo, primary, and Giordano, Silvia, primary

Published
2023
Full Text
View/download PDF

50. Supplementary Figure 2 from Inhibition of MEK and PI3K/mTOR Suppresses Tumor Growth but Does Not Cause Tumor Regression in Patient-Derived Xenografts of RAS-Mutant Colorectal Carcinomas

Author

Migliardi, Giorgia, primary, Sassi, Francesco, primary, Torti, Davide, primary, Galimi, Francesco, primary, Zanella, Eugenia R., primary, Buscarino, Michela, primary, Ribero, Dario, primary, Muratore, Andrea, primary, Massucco, Paolo, primary, Pisacane, Alberto, primary, Risio, Mauro, primary, Capussotti, Lorenzo, primary, Marsoni, Silvia, primary, Di Nicolantonio, Federica, primary, Bardelli, Alberto, primary, Comoglio, Paolo M., primary, Trusolino, Livio, primary, and Bertotti, Andrea, primary

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results